Revenue, last quarter
$6M
+73.4% vs same quarter last year
Net income
−$6M
+45.7% vs same quarter last year
EPS, diluted
−$0.06
+57.1% vs same quarter last year
Operating cash flow
−$6.1M
−9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $13.6M | −$35.6M |
| FY24 | $12.9M | −$40.7M |
| FY23 | $11M | −$44.2M |
| FY22 | $6.8M | −$44.2M |
| FY21 | $1.5M | −$64.9M |
| FY20 | $294K | −$23.4M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 49.8% | −273.4% | −262.3% |
| FY24 | 45.7% | −335.3% | −315.9% |
| FY23 | 43.1% | −436.1% | −401% |
| FY22 | 13.3% | −1084.2% | −649.2% |
| FY21 | −78% | −4336.1% | −4335% |
| FY20 | −162.2% | −7990.1% | −7968.4% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$29.1M |
| FY24 | −$39.2M |
| FY23 | −$42.6M |
| FY22 | −$72.9M |
| FY21 | −$49.9M |
| FY20 | −$23.1M |
| FY19 | - |
- Hyperfine
- Healthcare median
Show the numbers
| Year | Hyperfine | Healthcare median |
|---|---|---|
| FY25 | −262.3% | −30.6% |
| FY24 | −315.9% | −47% |
| FY23 | −401% | −58% |
| FY22 | −649.2% | −80.4% |
| FY21 | −4335% | −71.9% |
| FY20 | −7968.4% | −62.2% |
| FY19 | - | −46.3% |